Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence

A Randomized, Double-blind, Parallel, Placebo-controlled Study for the Assessment of the Safety and Efficacy of UISH001 for the Symptomatic Improvement of Urinary Incontinence

The purpose of this study is to determine if a new drug treatment is effective for the treatment of symptoms of urinary incontinence.

Inclusion Criteria:

• Women who have moderate to severe urge, stress or mixed Urinary Incontinence

Exclusion Criteria:

• Medical history of migraines, neurologic problems, swallowing disorder, stroke or severe depression.
• Medical history of heart failure, peripheral edema or moderate to severe asthma or chronic obstructive pulmonary disease (COPD)
• Certain restricted medications
• Any other condition that would interfere with the safety of the subject